» Articles » PMID: 38499550

In Vitro and in Vivo Investigation of a Thyroid Hormone System-specific Interaction with Triazoles

Abstract

Alterations in thyroid hormones (TH) and thyroid-stimulating hormone levels are frequently found following exposure to chemicals of concern. Dysregulation of TH levels can severely perturb physiological growth, metabolism, differentiation, homeostasis in the adult and developmental processes in utero. A frequently identified mode of action for this interaction is the induction of hepatic detoxification mechanisms (e.g. SULTs and UGTs), which lead to TH conjugation and elimination and therefore interfere with hormonal homeostasis, fulfilling the endocrine disruptors (EDs) definition. A short-term study in rats with dietary exposure to cyproconazole, epoxiconazole and prochloraz was conducted and hepatocyte hypertrophy, hepatic UGT activity and Phase 1/2 gene expression inductions were observed together with changes in TH levels and thyroid follicular hypertrophy and hyperplasia. To test for specific interaction with the thyroid hormone system, in vitro assays were conducted covering thyroidal I-uptake (NIS), TH transmembranal transport via MCT8 and thyroid peroxidase (TPO) function. Assays for iodothyronine deiodinases (DIO1-DIO3) and iodotyrosine deiodinase (DEHAL1) were included, and from the animal experiment, Dio1 and Dehal1 activities were measured in kidney and liver as relevant local indicators and endpoints. The fungicides did not affect any TH-specific KEs, in vitro and in vivo, thereby suggesting hepatic conjugation as the dominant MoA.

Citing Articles

Effects of Insecticide and Herbicides on Thyroid Disturbances in Zebrafish.

Ma T, An X, Wu P, He X, Luo Y Toxics. 2024; 12(8).

PMID: 39195672 PMC: 11358992. DOI: 10.3390/toxics12080570.

References
1.
Lossow K, Renko K, Schwarz M, Schomburg L, Schwerdtle T, Kipp A . The Nutritional Supply of Iodine and Selenium Affects Thyroid Hormone Axis Related Endpoints in Mice. Nutrients. 2021; 13(11). PMC: 8625755. DOI: 10.3390/nu13113773. View

2.
Huisinga M, Bertrand L, Chamanza R, Damiani I, Engelhardt J, Francke S . Adversity Considerations for Thyroid Follicular Cell Hypertrophy and Hyperplasia in Nonclinical Toxicity Studies: Results From the 6th ESTP International Expert Workshop. Toxicol Pathol. 2020; 48(8):920-938. DOI: 10.1177/0192623320972009. View

3.
Findlay K, Kaptein E, Visser T, Burchell B . Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab. 2000; 85(8):2879-83. DOI: 10.1210/jcem.85.8.6715. View

4.
Perez-Montiel M, Suster S . The spectrum of histologic changes in thyroid hyperplasia: a clinicopathologic study of 300 cases. Hum Pathol. 2008; 39(7):1080-7. DOI: 10.1016/j.humpath.2007.12.001. View

5.
Liu J, Liu Y, BARTER R, Klaassen C . Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J Pharmacol Exp Ther. 1995; 273(2):977-85. View